(Q61934354)
Statements
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of XP13512 in Patients With Restless Legs Syndrome. (English)
0 references
August 2006
0 references
December 2007
0 references
325
0 references
18 year
0 references